Substituted azole aromatic heterocycles as inhibitors of 11-beta-HSD-1

Details for Australian Patent Application No. 2007275301 (hide)

Owner Amgen Inc. Biovitrum AB

Inventors Sutin, Lori; Johansson, Lars; St. Jean, David; Haraldsson, Martin; Bartberger, Michael D.; Nilsson, Marianne; Fotsch, Christopher H.

Agent Knightsbridge Patent Attorneys

Pub. Number AU-A-2007275301

PCT Pub. Number WO2008/011453

Priority 60/924,520 18.05.07 US; 60/831,961 20.07.06 US

Filing date 18 July 2007

Wipo publication date 24 January 2008

International Classifications

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

26 February 2009 PCT application entered the National Phase

  PCT publication WO2008/011453 Priority application(s): WO2008/011453

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007275303-Stable adhesives from urea-denatured soy flour

2007275296-High hardness/high wear resistant iron based weld overlay materials